Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marcello Arca

Showing results (61-70 of 212) with videos related to

Pageof 22
Sort By:
Journal of Clinical Lipidology|June 10, 2025
Long-term experience with lomitapide treatment in patients with homozygous familial hypercholesterolemia: Over 10 years of efficacy and safety dataMarcello Arca, Laura D'Erasmo, Marina Cuchel, et al.
Frontiers in Public Health|May 1, 2025
The current stage of Italy in the implementation of genomics into the National Healthcare System: an application of the B1MG maturity level modelValentina Baccolini, Erica Pitini, Daniela Galeone, et al.
BMC Medical Genetics|September 11, 2003
Genetic study of common variants at the Apo E, Apo AI, Apo CIII, Apo B, lipoprotein lipase (LPL) and hepatic lipase (LIPC) genes and coronary artery disease (CAD): variation in LIPC gene associates with clinical outcomes in patients with established CADMarco G Baroni, Andrea Berni, Stefano Romeo, et al.
Journal of the American Heart Association|May 15, 2023
Lipoprotein(a) Genotype Influences the Clinical Diagnosis of Familial HypercholesterolemiaElena Olmastroni, Marta Gazzotti, Maurizio Averna, et al.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|August 25, 2020
Evolving trend in the management of heterozygous familial hypercholesterolemia in Italy: A retrospective, single center, observational studyLaura D'Erasmo, Daniela Commodari, Alessia Di Costanzo, et al.
Cardiology|March 20, 2010
Functional rs20417 SNP (-765G>C) of cyclooxygenase-2 gene does not predict the risk of recurrence of ischemic events in coronary patients: results of a 7-year prospective studyAnna Montali, Francesco Barillà, Gaetano Tanzilli, et al.
Giornale Italiano Di Cardiologia (2006)|June 17, 2016
[ANMCO Position paper: Diagnostic and therapeutic pathways in patients with hypercholesterolemia and statin intolerance]Michele Massimo Gulizia, Furio Colivicchi, Marcello Arca, et al.
Haematologica|January 29, 2003
Interleukin-1 gene cluster polymorphisms and risk of coronary artery diseaseBranislav Vohnout, Augusto Di Castelnuovo, Roberto Trotta, et al.
Biochemical and Biophysical Research Communications|December 4, 2018
A novel splicing mutation in the ABCA1 gene, causing Tangier disease and familial HDL deficiency in a large familyMarianna Maranghi, Gessica Truglio, Antonio Gallo, et al.
Human Molecular Genetics|September 20, 2012
Contribution of novel ATGL missense mutations to the clinical phenotype of NLSD-M: a strikingly low amount of lipase activity may preserve cardiac functionDaniela Tavian, Sara Missaglia, Chiara Redaelli, et al.
Pageof 22

Showing results (61-70 of 212) with videos related to

Sort By:
Pageof 22
Journal of Clinical Lipidology|June 10, 2025
Long-term experience with lomitapide treatment in patients with homozygous familial hypercholesterolemia: Over 10 years of efficacy and safety dataMarcello Arca, Laura D'Erasmo, Marina Cuchel, et al.
Frontiers in Public Health|May 1, 2025
The current stage of Italy in the implementation of genomics into the National Healthcare System: an application of the B1MG maturity level modelValentina Baccolini, Erica Pitini, Daniela Galeone, et al.
BMC Medical Genetics|September 11, 2003
Genetic study of common variants at the Apo E, Apo AI, Apo CIII, Apo B, lipoprotein lipase (LPL) and hepatic lipase (LIPC) genes and coronary artery disease (CAD): variation in LIPC gene associates with clinical outcomes in patients with established CADMarco G Baroni, Andrea Berni, Stefano Romeo, et al.
Journal of the American Heart Association|May 15, 2023
Lipoprotein(a) Genotype Influences the Clinical Diagnosis of Familial HypercholesterolemiaElena Olmastroni, Marta Gazzotti, Maurizio Averna, et al.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|August 25, 2020
Evolving trend in the management of heterozygous familial hypercholesterolemia in Italy: A retrospective, single center, observational studyLaura D'Erasmo, Daniela Commodari, Alessia Di Costanzo, et al.
Cardiology|March 20, 2010
Functional rs20417 SNP (-765G>C) of cyclooxygenase-2 gene does not predict the risk of recurrence of ischemic events in coronary patients: results of a 7-year prospective studyAnna Montali, Francesco Barillà, Gaetano Tanzilli, et al.
Giornale Italiano Di Cardiologia (2006)|June 17, 2016
[ANMCO Position paper: Diagnostic and therapeutic pathways in patients with hypercholesterolemia and statin intolerance]Michele Massimo Gulizia, Furio Colivicchi, Marcello Arca, et al.
Haematologica|January 29, 2003
Interleukin-1 gene cluster polymorphisms and risk of coronary artery diseaseBranislav Vohnout, Augusto Di Castelnuovo, Roberto Trotta, et al.
Biochemical and Biophysical Research Communications|December 4, 2018
A novel splicing mutation in the ABCA1 gene, causing Tangier disease and familial HDL deficiency in a large familyMarianna Maranghi, Gessica Truglio, Antonio Gallo, et al.
Human Molecular Genetics|September 20, 2012
Contribution of novel ATGL missense mutations to the clinical phenotype of NLSD-M: a strikingly low amount of lipase activity may preserve cardiac functionDaniela Tavian, Sara Missaglia, Chiara Redaelli, et al.
Pageof 22